NCT03202186View on ClinicalTrials.gov

Study of Progesterone in Treatment of Vasomotor Symptoms

PHASE3TerminatedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

December 6, 2018

Study Completion Date

December 6, 2018

Conditions

Menopause Related Conditions

Interventions

DRUG

Progesterone oral capsule

Oral capsule treatment

DRUG

Placebo oral capsule

Oral capsule treatment

Trial Locations (1)

Unknown

Fachärztin für Gynäkologie und Geburtshilfe, Bernburg

Sponsors

Lead Sponsor

BHR Pharma, LLC

All Listed Sponsors

lead

BHR Pharma, LLC

INDUSTRY

NCT03202186 - Study of Progesterone in Treatment of Vasomotor Symptoms | Biotech Hunter | Biotech Hunter